triptolide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dandawate, P; Ganguly, S; Home, T; Kambhampati, S; McGuirk, J; Padhye, S; Rao, R; Saluja, AK; Shi, H; Yacoub, A | 1 |
1 other study(ies) available for triptolide and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.
Topics: Acetylation; Animals; Antineoplastic Agents, Alkylating; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultured; Diterpenes; DNA-Binding Proteins; Epoxy Compounds; Flow Cytometry; Fluorescent Antibody Technique; Heat Shock Transcription Factors; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Immunoprecipitation; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Organophosphates; Phenanthrenes; RNA, Small Interfering; Transcription Factors; Xenograft Model Antitumor Assays | 2015 |